State Of Wyoming Innoviva, Inc. Transaction History

State Of Wyoming

$676 Million
Q3 2024

A detailed history of State Of Wyoming transactions in Innoviva, Inc. stock. As of the latest transaction made, State Of Wyoming holds 17,318 shares of INVA stock, worth $318,131. This represents 0.05% of its overall portfolio holdings.

Number of Shares

17,318

Previous 5,405 220.41%

Holding current value

$318,131

Previous $88,000 279.55%

% of portfolio

0.05%

Previous 0.01%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$16.33 - $20.04 $194,539 - $238,736	11,913 Added 220.41%	17,318 $334,000
Q2 2024 Aug 14, 2024	SELL	$14.4 - $16.4 $143,438 - $163,360	-9,961 Reduced 64.82%	5,405 $88,000
Q1 2024 May 13, 2024	BUY	$14.56 - $16.78 $181,810 - $209,531	12,487 Added 433.73%	15,366 $234,000
Q4 2023 Feb 14, 2024	SELL	$12.32 - $16.27 $135,704 - $179,214	-11,015 Reduced 79.28%	2,879 $46,000
Q3 2023 Nov 14, 2023	SELL	$12.37 - $13.89 $24 - $27	-2 Reduced 0.01%	13,894 $180,000
Q2 2023 Aug 14, 2023	SELL	$11.39 - $13.72 $7,859 - $9,466	-690 Reduced 4.73%	13,896 $176,000
Q1 2023 May 12, 2023	BUY	$10.73 - $13.6 $84,359 - $106,923	7,862 Added 116.92%	14,586 $164,000
Q4 2022 Feb 14, 2023	SELL	$11.8 - $13.78 $41,311 - $48,243	-3,501 Reduced 34.24%	6,724 $89,000
Q3 2022 Nov 14, 2022	BUY	$11.61 - $15.22 $16,195 - $21,231	1,395 Added 15.8%	10,225 $119,000
Q2 2022 Aug 15, 2022	BUY	$14.32 - $19.88 $7,646 - $10,615	534 Added 6.44%	8,830 $130,000
Q1 2022 May 13, 2022	SELL	$15.39 - $20.25 $5,448 - $7,168	-354 Reduced 4.09%	8,296 $161,000
Q4 2021 Feb 11, 2022	BUY	$15.91 - $18.72 $137,621 - $161,928	8,650 New	8,650 $149,000

Others Institutions Holding INVA

# of Institutions

228

Shares Held

79.1M

Call Options Held

37.6K

Put Options Held

300

View Full List

About Innoviva, Inc.

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.28B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

More about INVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wyoming with notifications on news.

Account